← back to search

Benjamin Krämer

Cleveland Clinic · US
Area of research
Pulmonary and Respiratory Medicine · Immunology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Immune Cell Function and Interaction, Hepatitis C virus research, and Respiratory Support and Mechanisms.
h-index
48
citations
11,405
works
313
NIH funding
primary concept
Chemistry
email

Recent publications

IL-17A-producing NKp44(−) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue
Nature Communications 2025cited by 2position: middledoi
IL-17A-producing NKp44(-) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue.
2025cited by 1position: contributordoi
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Cell 2024cited by 27position: middledoi
Catecholamines and inflammation in advanced liver disease: more closely intertwined than expected?
2024cited by 0position: contributordoi
Single-cell RNA sequencing identifies a population of human liver-type ILC1s
Cell Reports 2023cited by 36position: firstdoi
Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
2023cited by 27position: contributordoi
IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis.
2023cited by 12position: contributordoi
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis.
2023cited by 12position: contributordoi
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis
JHEP Reports 2023cited by 6position: contributordoi
HIV-Associated Microbial Translocation May Affect Cytokine Production of CD56bright NK Cells via Stimulation of Monocytes.
2023cited by 4position: contributordoi
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.
2022cited by 23position: contributordoi
Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral Therapy.
2022cited by 7position: contributordoi
Genetic Variation of <i>SAMM50</i> Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients.
2022cited by 4position: contributordoi
Swarm Learning for decentralized and confidential clinical machine learning
Nature 2021cited by 822position: middledoi
Swarm Learning for decentralized and confidential clinical machine learning
Nature 2021cited by 752position: contributordoi
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
Immunity 2021cited by 257position: firstdoi
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
2021cited by 217position: contributordoi
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
2021cited by 198position: contributordoi
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Cell 2020cited by 1,595position: middledoi
Suppressive myeloid cells are a hallmark of severe COVID-19
2020cited by 11position: contributordoi
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
2019cited by 114position: contributordoi
NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response
Frontiers in Immunology 2019cited by 10position: middledoi
The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.
2019cited by 9position: contributordoi
NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response.
2019cited by 7position: contributordoi
Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis
Hepatology 2014cited by 125position: middledoi
Effect of once‐daily indacaterol in a predominantly <scp>C</scp>hinese population with chronic obstructive pulmonary disease: A 26‐week <scp>A</scp>sia‐<scp>P</scp>acific study
Respirology 2014cited by 19position: lastdoi
Activation of Invariant NK T Cells in Periodontitis Lesions
The Journal of Immunology 2013cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jacob Nattermann · Marymount University5 papers (2023–2025) · 4 papers (2019–2023)Hans Dieter Nischalke · University Hospital Bonn4 papers (2019–2023)Christian P. Strassburg · Heinrich Heine University Düsseldorf3 papers (2019–2024) · 3 papers (2023–2024)Dominik J. Kaczmarek · University of Bonn3 papers (2023–2025)Stephan Buch · Heinrich Heine University Düsseldorf3 papers (2019–2023)Thomas Berg · League Against Cancer2 papers (2022–2023)Christoph Hoffmeister · University of Bonn2 papers (2023–2023)Ulisses Nunes da Rocha · Helmholtz Centre for Environmental Research2 papers (2021–2021) · 2 papers (2023–2024) · 2 papers (2023–2025)Michael ToVinh · University Hospital Bonn2 papers (2023–2023)Nikolaus Rajewsky · Innovation Cluster (Canada)2 papers (2021–2021)Jörg Janne Vehreschild · Universitätsmedizin Göttingen2 papers (2021–2021) · 2 papers (2022–2023) · 2 papers (2023–2023)Jan Raabe · University of Freiburg2 papers (2023–2023)Oliver Stegle · Institut thématique Génétique, génomique et bioinformatique2 papers (2021–2021)Andreas Diefenbach · German Center for Lung Research2 papers (2021–2021)